Neuroscience Research Institute

West Palm Beach, Florida 33407

3 studies enrolling now · 11 studies all time

What they study most

Alzheimer's Disease Psychosis, Anhedonia, Attention Deficit/Hyperactivity Disorder, Bipolar Disorder, Cannabis Withdrawal, Depressive Disorder, Major, Depressive Disorder, Treatment-Resistant, Major Depressive Disorder, Schizophrenia

Studies at this site

• Efficacy of PP-01 in Mitigating Cannabis Withdrawal Symptoms in Adults With Cannabis Use Disorder — Recruiting now
• A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder — Recruiting now
• ACP-204 in Adults With Alzheimer's Disease Psychosis — Recruiting now
• A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder. — Completed
• Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD) — Completed
• A Study of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy and Long-term Extension Treatment With Aticaprant — Stopped early
• Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression — Completed
• BHV-7000 Open-Label Extension Bipolar Mania Study — Stopped early
• BHV-7000 Acute Treatment of Bipolar Mania — Completed
• An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-5) — Completed
• A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression — Completed